Special Issue

COVID-19 in Pregnancy

Submission Deadline: 31 Aug 2023

Guest Editor

  • Portrait of Guest Editor Luca  Roncati

    Luca Roncati MD

    Department of Life Sciences, Health, and Health Care Professions, Link Campus University, Rome, Italy

    Interests: gynaecopathology; gynaecological oncology; molecular oncology; human papilloma virus; PAP smear; breast cancer; target therapy; precision oncology; endocrine disruptors; SIDS; COVID-19

    Special Issue in IMR Press journals

Special Issue Information

Dear Colleagues,

It was 11 March 2020, when the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic, which would later shock the entire globe. Among the people most vulnerable to infection are pregnant women due to rearrangements in the immune and angiotensin systems. To combat COVID-19, specific and innovative vaccines have been launched in record time by conditional marketing authorization, whose long-term effects on the mother, fetus and newborn are not yet known. There are still limited data on the implications of COVID-19 infections for labor, although an increased risk of preterm delivery has been reported. Early studies indicated no evidence for vertical mother-to-child transmission of COVID-19 in late pregnancy, but more recent findings show that vertical transmission can occur in some cases. The aim and scope of this Special Issue is therefore to collect as much up-to-date information as possible on COVID-19 in pregnancy through a multidisciplinary approach.

Dr. Luca Roncati

Guest Editor

Keywords

  • COVID-19
  • SARS-CoV-2
  • Th1
  • Th2
  • ACE
  • ACE2
  • angiotensin
  • pregnancy
  • preterm labor
  • miscarriage
  • placenta
  • fetus
  • fetoplacental pathology
  • vaccines

Published Papers (3)

Open Access Original Research
193
156
Open Access Systematic Review
201
61
Open Access Original Research
122
95

Share